Rare diseases
Investigational molecules
Locations
Via Lorenz Böhler 5, 39100 Bolzano, Italy
Azienda Sanitaria dell'Alto Adige-Comprensorio sanitario di Bolzano in Bolzano, Italy specialises in clinical trials of conditions such as Mantle cell lymphoma stage II, Mantle cell lymphoma stage III, Mantle cell lymphoma stage IV, Triple negative breast cancer, and other specialisations. This site conducts important research.
The medical center is at the forefront of oncology research, with a particular focus on breast cancer. The institution is dedicated to advancing treatment options for patients with high-risk triple negative breast cancer, a challenging subtype of breast cancer known for its aggressive nature and limited treatment options.
Through its research, the center is exploring the efficacy of anti-PD-L1 antibodies like avelumab, aiming to enhance disease-free survival rates in patients who have undergone comprehensive treatment regimens. This work is pivotal in shaping future therapeutic protocols and improving patient outcomes.
Clinical trials registered at this site – none is enrolling right now.
Study on Avelumab for Patients with High-Risk Triple Negative Breast Cancer
ItalyStudy on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma
ItalyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
